PT - JOURNAL ARTICLE AU - Artem Nemudryi AU - Anna Nemudraia AU - Tanner Wiegand AU - Kevin Surya AU - Murat Buyukyoruk AU - Karl K Vanderwood AU - Royce Wilkinson AU - Blake Wiedenheft TI - Temporal detection and phylogenetic assessment of SARS-CoV-2 in municipal wastewater AID - 10.1101/2020.04.15.20066746 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.15.20066746 4099 - http://medrxiv.org/content/early/2020/07/05/2020.04.15.20066746.short 4100 - http://medrxiv.org/content/early/2020/07/05/2020.04.15.20066746.full AB - SARS-CoV-2 has recently been detected in feces, which indicates that wastewater may be used to monitor viral prevalence in the community. Here we use RT-qPCR to monitor wastewater for SARS-CoV-2 RNA over a 52-day time course. We show that changes in SARS-CoV-2 RNA concentrations correlate with local COVID-19 epidemiological data (R2=0.9), though detection in wastewater trails symptom onset dates by 5-8 days. We determine a near complete (98.5%) SARS-CoV-2 genome sequence from the wastewater and use phylogenic analysis to infer viral ancestry. Collectively, this work demonstrates how wastewater can be used as a proxy to monitor viral prevalence in the community and how genome sequencing can be used for high-resolution genotyping of the predominant strains circulating in a community.Competing Interest StatementB.W. is the founder of SurGene, LLC, and is an inventor on patent applications related to CRISPR-Cas systems and applications thereof.Funding StatementThis work was supported by the National Institutes of Health (1R35GM134867), the Montana State University Agricultural Experimental Station, the MJ Murdock Charitable Trust, the Gianforte Foundation and the MSU Office of the Vice President for Research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are is available on request from the authors. SARS-CoV-2 genome sequence from wastewater sequence was uploaded to GISAID (https://www.gisaid.org/), accession ID: EPI_ISL_437434.